Methimazole

thyroid stimulating hormone receptor ; Homo sapiens







16 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34544941 A case of Graves' disease presenting with internal ophthalmoplegia during methylmercaptoimidazole treatment. 2022 Feb 28 1
2 35228417 A Case of Graves' Disease with Thymic Hyperplasia: The Response of the Thyroid Function, Thyrotropin Receptor Autoantibody, and Thymic Size to Thiamazole Treatment. 2022 Feb 26 2
3 34027861 The Relationship between Third-generation TSH Receptor Antibody Positivity and Cumulative Methimazole Dose Used until Remission in Graves' Disease. 2021 May 2
4 30753531 High Titers of Thyrotropin Receptor Antibodies Are Associated With Orbitopathy in Patients With Graves Disease. 2019 Jul 1 1
5 30705666 Active Moderate-to-Severe Graves' Orbitopathy in a Patient With Type 2 Diabetes Mellitus and Vascular Complications. 2018 1
6 27927064 Clinical efficacy of Yingliu mixture combined with metimazole for treating diffuse goitre with hyperthyroidism and its impact on related cytokines. 2017 Dec 1
7 28162094 Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report. 2017 Feb 6 1
8 18964302 Treatment of Graves' disease with rituximab specifically reduces the production of thyroid stimulating autoantibodies. 2009 Mar 2
9 16571093 Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period. 2006 Mar 2
10 9222097 Analysis of IL-2 and IL-6 binding to peripheral blood lymphocytes in Graves disease: relationship with disease activity. 1997 Jun 15 1
11 9309534 Prospective study on thyroid autoimmunity and dysfunction related to chronic hepatitis C and interferon therapy. 1997 Jul-Aug 1
12 8784084 Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease. 1996 Sep 1
13 7551709 In vitro suppression of anti-TSH receptor antibody by autologous anti-idiotypic antibody in patients with Graves' disease. 1995 2
14 2896115 [Clinical relevance of the determination of TSH-binding inhibitory immunoglobulins (TBII) in patients with immunogenic hyperthyroidism in methimazole therapy]. 1987 1
15 2946953 Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease. 1987 Jan 1 1
16 2869050 Methimazole, but not betamethasone, prevents 131I treatment-induced rises in thyrotropin receptor autoantibodies in hyperthyroid Graves' disease. 1986 Apr 1